| Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008 M Björkholm, L Ohm, S Eloranta, Å Derolf, M Hultcrantz, J Sjöberg, ... Journal of Clinical Oncology 29 (18), 2514, 2011 | 248 | 2011 |
| Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study M Hultcrantz, SY Kristinsson, TML Andersson, O Landgren, S Eloranta, ... Journal of clinical oncology 30 (24), 2995, 2012 | 237 | 2012 |
| 15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL 2): prolonged remissions without survival plateau CW Eskelund, A Kolstad, M Jerkeman, R Räty, A Laurell, S Eloranta, ... British journal of haematology 175 (3), 410-418, 2016 | 220 | 2016 |
| Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study A Leval, E Herweijer, A Ploner, S Eloranta, J Fridman Simard, J Dillner, ... Journal of the National Cancer Institute 105 (7), 469-474, 2013 | 197 | 2013 |
| The prevalence of mental health problems in elite athletes C Åkesdotter, G Kenttä, S Eloranta, J Franck Journal of science and medicine in sport 23 (4), 329-335, 2020 | 183 | 2020 |
| Cancer incidence, survival and mortality: explaining the concepts L Ellis, LM Woods, J Estève, S Eloranta, MP Coleman, B Rachet International journal of cancer 135 (8), 1774-1782, 2014 | 181 | 2014 |
| Duration of red blood cell storage and survival of transfused patients (CME) G Edgren, M Kamper‐Jørgensen, S Eloranta, K Rostgaard, B Custer, ... Transfusion 50 (6), 1185-1195, 2010 | 168 | 2010 |
| Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models TML Andersson, PW Dickman, S Eloranta, PC Lambert BMC medical research methodology 11, 1-11, 2011 | 142 | 2011 |
| Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based study M Hultcrantz, SR Wilkes, SY Kristinsson, TML Andersson, ÅR Derolf, ... Journal of Clinical Oncology 33 (20), 2288-2295, 2015 | 137 | 2015 |
| Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study SY Kristinsson, M Björkholm, TML Andersson, S Eloranta, PW Dickman, ... haematologica 94 (12), 1714, 2009 | 137 | 2009 |
| Estimating the loss in expectation of life due to cancer using flexible parametric survival models TML Andersson, PW Dickman, S Eloranta, M Lambe, PC Lambert Statistics in medicine 32 (30), 5286-5300, 2013 | 135 | 2013 |
| Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma E Herweijer, A Leval, A Ploner, S Eloranta, JF Simard, J Dillner, ... Jama 311 (6), 597-603, 2014 | 117 | 2014 |
| Prospective study of human papillomavirus and risk of cervical adenocarcinoma LA Dahlström, N Ylitalo, K Sundström, J Palmgren, A Ploner, S Eloranta, ... International journal of cancer 127 (8), 1923-1930, 2010 | 111 | 2010 |
| Validation of data quality in the Swedish National Register for Breast Cancer L Löfgren, S Eloranta, K Krawiec, A Asterkvist, C Lönnqvist, K Sandelin, ... BMC Public Health 19, 1-11, 2019 | 92 | 2019 |
| Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix K Sundström, S Eloranta, P Sparén, L Arnheim Dahlström, A Gunnell, ... Cancer epidemiology, biomarkers & prevention 19 (10), 2469-2478, 2010 | 91 | 2010 |
| Cancer survival statistics for patients and healthcare professionals–a tutorial of real‐world data analysis S Eloranta, KE Smedby, PW Dickman, TM Andersson Journal of internal medicine 289 (1), 12-28, 2021 | 84 | 2021 |
| The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma–a Swedish population-based study M Mohammadi, Y Cao, I Glimelius, M Bottai, S Eloranta, KE Smedby BMC cancer 15, 1-12, 2015 | 84 | 2015 |
| Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population‐based study of 1,555 patients diagnosed in Sweden from 1980 to 2005 SY Kristinsson, S Eloranta, PW Dickman, TML Andersson, I Turesson, ... American journal of hematology 88 (1), 60-65, 2013 | 74 | 2013 |
| Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer—a prospective … A Marklund, S Eloranta, I Wikander, ML Kitlinski, M Lood, E Nedstrand, ... Human Reproduction 35 (4), 929-938, 2020 | 71 | 2020 |
| Safety of fertility preservation in breast cancer patients in a register-based matched cohort study KA Rodriguez-Wallberg, S Eloranta, K Krawiec, A Lissmats, J Bergh, ... Breast cancer research and treatment 167, 761-769, 2018 | 68 | 2018 |
